Overall Approach to the Evaluation and Treatment of Osteoporosis in Men

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter intends to integrate the information concerning many of the factors concerning clinical evaluation of osteoporosis in men and the process of therapeutic intervention in a way that yields a current approach for use in clinical situations. Unfortunately, guidelines for efficient, cost-effective evaluations of patients having, or suspected of having, osteoporosis are poorly validated for either sex. Current practice is based on existing knowledge of the epidemiology and clinical characteristics of osteoporosis rather than upon models that have been carefully tested in prospective studies. Nevertheless, the information available concerning men has expanded considerably in the last decade and allows the formulation of a reasonable approach. Bone mineral density (BMD) is highly predictive of fracture risk in men and, in patients who have experienced fracture or who have conditions associated with low BMD, the measurement of BMD should be strongly considered. As above, clinical judgment is needed to make a decision to measure bone density in men with the conditions not so clearly related to fracture risk. In these situations, BMD measurements can be useful in several ways, including contributing to the diagnosis of skeletal fragility, gauging its severity and guiding decisions concerning therapy. Therefore, bone mineral density measurements have become a common part of the evaluation of fracture risk in men, but there are a number of challenging issues that still confront the choice and interpretation of those measures.

Original languageEnglish (US)
Title of host publicationOsteoporosis in Men
PublisherElsevier Inc.
Pages589-601
Number of pages13
ISBN (Print)9780123746023
DOIs
StatePublished - 2010

Fingerprint

Bone Density
Osteoporosis
Bone
Minerals
Therapeutics
Epidemiology
Gaging
Prospective Studies
Guidelines
Costs and Cost Analysis
Costs

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Overall Approach to the Evaluation and Treatment of Osteoporosis in Men. / Orwoll, Eric.

Osteoporosis in Men. Elsevier Inc., 2010. p. 589-601.

Research output: Chapter in Book/Report/Conference proceedingChapter

Orwoll, Eric. / Overall Approach to the Evaluation and Treatment of Osteoporosis in Men. Osteoporosis in Men. Elsevier Inc., 2010. pp. 589-601
@inbook{1f972d3ab8b544f8b24a5d384d0572a2,
title = "Overall Approach to the Evaluation and Treatment of Osteoporosis in Men",
abstract = "This chapter intends to integrate the information concerning many of the factors concerning clinical evaluation of osteoporosis in men and the process of therapeutic intervention in a way that yields a current approach for use in clinical situations. Unfortunately, guidelines for efficient, cost-effective evaluations of patients having, or suspected of having, osteoporosis are poorly validated for either sex. Current practice is based on existing knowledge of the epidemiology and clinical characteristics of osteoporosis rather than upon models that have been carefully tested in prospective studies. Nevertheless, the information available concerning men has expanded considerably in the last decade and allows the formulation of a reasonable approach. Bone mineral density (BMD) is highly predictive of fracture risk in men and, in patients who have experienced fracture or who have conditions associated with low BMD, the measurement of BMD should be strongly considered. As above, clinical judgment is needed to make a decision to measure bone density in men with the conditions not so clearly related to fracture risk. In these situations, BMD measurements can be useful in several ways, including contributing to the diagnosis of skeletal fragility, gauging its severity and guiding decisions concerning therapy. Therefore, bone mineral density measurements have become a common part of the evaluation of fracture risk in men, but there are a number of challenging issues that still confront the choice and interpretation of those measures.",
author = "Eric Orwoll",
year = "2010",
doi = "10.1016/B978-0-12-374602-3.00048-1",
language = "English (US)",
isbn = "9780123746023",
pages = "589--601",
booktitle = "Osteoporosis in Men",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Overall Approach to the Evaluation and Treatment of Osteoporosis in Men

AU - Orwoll, Eric

PY - 2010

Y1 - 2010

N2 - This chapter intends to integrate the information concerning many of the factors concerning clinical evaluation of osteoporosis in men and the process of therapeutic intervention in a way that yields a current approach for use in clinical situations. Unfortunately, guidelines for efficient, cost-effective evaluations of patients having, or suspected of having, osteoporosis are poorly validated for either sex. Current practice is based on existing knowledge of the epidemiology and clinical characteristics of osteoporosis rather than upon models that have been carefully tested in prospective studies. Nevertheless, the information available concerning men has expanded considerably in the last decade and allows the formulation of a reasonable approach. Bone mineral density (BMD) is highly predictive of fracture risk in men and, in patients who have experienced fracture or who have conditions associated with low BMD, the measurement of BMD should be strongly considered. As above, clinical judgment is needed to make a decision to measure bone density in men with the conditions not so clearly related to fracture risk. In these situations, BMD measurements can be useful in several ways, including contributing to the diagnosis of skeletal fragility, gauging its severity and guiding decisions concerning therapy. Therefore, bone mineral density measurements have become a common part of the evaluation of fracture risk in men, but there are a number of challenging issues that still confront the choice and interpretation of those measures.

AB - This chapter intends to integrate the information concerning many of the factors concerning clinical evaluation of osteoporosis in men and the process of therapeutic intervention in a way that yields a current approach for use in clinical situations. Unfortunately, guidelines for efficient, cost-effective evaluations of patients having, or suspected of having, osteoporosis are poorly validated for either sex. Current practice is based on existing knowledge of the epidemiology and clinical characteristics of osteoporosis rather than upon models that have been carefully tested in prospective studies. Nevertheless, the information available concerning men has expanded considerably in the last decade and allows the formulation of a reasonable approach. Bone mineral density (BMD) is highly predictive of fracture risk in men and, in patients who have experienced fracture or who have conditions associated with low BMD, the measurement of BMD should be strongly considered. As above, clinical judgment is needed to make a decision to measure bone density in men with the conditions not so clearly related to fracture risk. In these situations, BMD measurements can be useful in several ways, including contributing to the diagnosis of skeletal fragility, gauging its severity and guiding decisions concerning therapy. Therefore, bone mineral density measurements have become a common part of the evaluation of fracture risk in men, but there are a number of challenging issues that still confront the choice and interpretation of those measures.

UR - http://www.scopus.com/inward/record.url?scp=84882831348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882831348&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374602-3.00048-1

DO - 10.1016/B978-0-12-374602-3.00048-1

M3 - Chapter

SN - 9780123746023

SP - 589

EP - 601

BT - Osteoporosis in Men

PB - Elsevier Inc.

ER -